With HF (n=85) | Without HF (n=1275) | Number of missings | P value | |
Gender (female) | 20 (23.5) | 261 (20.5) | 0 | 0.500 |
Mean age in years at index infarction (SD) | 59.9 (10.3) | 57.2 (10.7) | 0 | <0.001 |
VF at index MI | 41 (48.2) | 527 (41.3) | 0 | 0.212 |
Cardiovascular risk profile | ||||
Mean BMI (SD) | 26.6 (3.9) | 26.6 (3.9) | 61 | 0.806 |
FH of CVD | 62 (77.5) | 817 (65.8) | 39 | 0.032 |
Current smoker | 50 (59.5) | 767 (61.5) | 29 | 0.718 |
Diabetes | 8 (9.6) | 94 (7.6) | 41 | 0.502 |
Hypertension | 32 (39) | 378 (31.3) | 72 | 0.148 |
Atrial fibrillation | 5 (6.1) | 17 (1.4) | 58 | 0.001 |
High cholesterol | 17 (22.7) | 378 (32.1) | 109 | 0.087 |
FH of sudden death | 34 (41) | 330 (26.1) | 14 | 0.006 |
Angina 48 hours before STEMI | 37 (45.1) | 455 (36.6) | 35 | 0.122 |
Cardiac medication before STEMI | ||||
β-blocker | 13 (15.7) | 120 (9.6) | 24 | 0.073 |
Statins | 3 (3.6) | 133 (10.6) | 24 | 0.041 |
Diuretics | 5 (6.1) | 79 (6.3) | 23 | 0.943 |
ACE inhibitors/ARB | 11 (13.3) | 98 (7.8) | 26 | 0.080 |
Aspirin/oral anticoagulation | 9 (10.8) | 103 (8.2) | 22 | 0.401 |
Numbers in the columns with and without HF denote n (%), unless specified otherwise.
ARB, angiotensin receptor blocker; BMI, body mass index; CVD, cardiovascular disease; FH, family history; HF, heart failure; MI, myocardial infarction; STEMI, ST-elevation myocardial infarction; VF, ventricular fibrillation.